Triojection (system of treatment of intervertebral hernias)

History

2025: Product Announcement

In mid-August 2025, SpinaFX Medical announced the release of a specialized Triojection system designed to treat intervertebral hernias. Therapy is carried out with the help of oxygen and ozone.

An intervertebral hernia is one of the most common causes of pain in the lower back. The ailment is associated with the protrusion of a part of the intervertebral disc from the space between the bodies of the vertebrae. By squeezing nerve structures and other tissues, the formations can cause stress and rest pain, numbness, and loss of sensation in the limbs. Often, an intervertebral hernia requires surgical treatment. The disease can lead to disability and disability.

𝓲

Фото: medicaldevice-network.com

Triojection is a visually supervised procedure based on the application of a patented oxygen and ozone supply system to treat the affected intervertebral disc. During the operation, doctors introduce a special syringe cartridge into the disk, which directs a mixture of oxygen and ozone to reduce pressure inside the disk and reduce compression of nearby nerves.

SpinaFX Medical has developed an approach that allows you to accurately affect the hernia area without damaging the surrounding tissue. The method can be used in hospitals, outpatient surgical centers or clinics with minimal infrastructure requirements, which makes it suitable, among other things, for institutions with limited resources.

SpinaFX Medical notes that intervertebral hernias in the lumbar region are one of the leading causes of disability worldwide. Either conservative methods that may not bring relief or invasive surgical procedures associated with risks and longer recovery are often used for treatment. Triojection offers an effective alternative to such interventions.^[1]

Notes